Mark Timney, Attralus CEO (via Purdue Pharma on YouTube)
September 8, 2021 10:42 AM EDT
People
Financing

A few months in­to his new role at At­tralus, ex-Pur­due chief Mark Tim­ney leads the biotech to a $116M round

Nicole DeFeudis

Editor

Months af­ter Bay Area start­up At­tralus tapped Mark Tim­ney to its helm, the ex-Pur­due Phar­ma chief has led the com­pa­ny to a $116 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er wants in on Sum­mit’s goal to beat Keytru­da via ADC com­bos

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

Sanofi, Te­va bol­ster case for IBD drug with Phase 2 da­ta, de­spite po­ten­tial com­pe­ti­tion

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times